Biodexa Pharmaceuticals (BDRX) Short term Debt (2015 - 2025)
Biodexa Pharmaceuticals (BDRX) reported Short term Debt of $81140.1 for Q4 2025, down 89.62% on a YoY basis from $781652.6 in Q4 2024, and down 89.62% sequentially from $781652.6 in Q4 2024.
Biodexa Pharmaceuticals (BDRX) Short term Debt (2015 - 2025) Analysis & Trends
Biodexa Pharmaceuticals (BDRX) has 11 years of Short term Debt data on file, last reported at $81140.1 in Q4 2025.
- For the quarter ending Q4 2025, Short term Debt fell 89.62% year-over-year to $81140.1; the trailing twelve-month figure through Dec 2025 stood at $81140.1 (down 89.62% YoY), and the FY2025 full-year result was $80429.1, down 89.71% from the prior year.
- Short term Debt eased to $81140.1 in Q4 2025, from $781652.6 in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $781652.6 in Q4 2024 to a low of $81140.1 in Q4 2025.
- A 5-year average of $291639.7 and a median of $196809.5 in 2021 frame the typical range for Short term Debt.
- Across the five-year window, Short term Debt surged 272.65% in 2024 and slumped 89.62% in 2025, its largest moves.
- Tracing BDRX's Short term Debt over 5 years: stood at $196809.5 in 2021, then retreated by 4.05% to $188841.5 in 2022, then advanced by 11.07% to $209754.7 in 2023, then surged by 272.65% to $781652.6 in 2024, then plunged by 89.62% to $81140.1 in 2025.
- Business Quant data shows BDRX's Short term Debt at $81140.1 in Q4 2025, $781652.6 in Q4 2024, and $209754.7 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Biodexa Pharmaceuticals | 18.43 Bn | 18.43 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 81,140.14 |
| Dec 31, 2024 | 781,652.62 |
| Dec 31, 2023 | 209,754.67 |
| Dec 31, 2022 | 188,841.46 |
| Dec 31, 2021 | 196,809.55 |
| Dec 31, 2020 | 264,090.20 |
| Dec 31, 2019 | 529,718.66 |
| Dec 31, 2018 | 5,147.07 |
| Dec 31, 2017 | 479,287.01 |
| Dec 31, 2016 | 668,853.58 |
| Dec 31, 2015 | 670,730.82 |